AR111697A2 - OPHTHALM COMPOSITION FOR THE TREATMENT OF EYE ALLERGIES - Google Patents

OPHTHALM COMPOSITION FOR THE TREATMENT OF EYE ALLERGIES

Info

Publication number
AR111697A2
AR111697A2 ARP180101296A ARP180101296A AR111697A2 AR 111697 A2 AR111697 A2 AR 111697A2 AR P180101296 A ARP180101296 A AR P180101296A AR P180101296 A ARP180101296 A AR P180101296A AR 111697 A2 AR111697 A2 AR 111697A2
Authority
AR
Argentina
Prior art keywords
treatment
ophthalm
composition
eye allergies
allergies
Prior art date
Application number
ARP180101296A
Other languages
Spanish (es)
Original Assignee
Vistakon Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vistakon Pharmaceuticals Llc filed Critical Vistakon Pharmaceuticals Llc
Publication of AR111697A2 publication Critical patent/AR111697A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones, kits y métodos para el tratamiento o prevención de las alergias e inflamación oculares y los síntomas de las mismas, que comprenden alcaftadina o una sal farmacéuticamente aceptable de la misma.Compositions, kits and methods for the treatment or prevention of eye allergies and inflammation and the symptoms thereof, which comprise alkaltadine or a pharmaceutically acceptable salt thereof.

ARP180101296A 2006-03-31 2018-05-16 OPHTHALM COMPOSITION FOR THE TREATMENT OF EYE ALLERGIES AR111697A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78818506P 2006-03-31 2006-03-31

Publications (1)

Publication Number Publication Date
AR111697A2 true AR111697A2 (en) 2019-08-07

Family

ID=40770601

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180101296A AR111697A2 (en) 2006-03-31 2018-05-16 OPHTHALM COMPOSITION FOR THE TREATMENT OF EYE ALLERGIES

Country Status (3)

Country Link
CN (1) CN101460176B (en)
AR (1) AR111697A2 (en)
UA (1) UA94938C2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108368118B (en) * 2016-06-07 2021-03-02 深圳市塔吉瑞生物医药有限公司 Substituted condensed imidazole ring compound and pharmaceutical composition thereof
CN107854470B (en) * 2016-09-21 2020-03-27 武汉武药科技有限公司 Acatadine composition, preparation method and application thereof
PT3740191T (en) * 2018-01-18 2021-07-09 Faes Farma Sa Ophthalmic compositions comprising bilastine, a beta-cyclodextrin and at least one gelling agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions

Also Published As

Publication number Publication date
UA94938C2 (en) 2011-06-25
CN101460176B (en) 2012-11-28
CN101460176A (en) 2009-06-17

Similar Documents

Publication Publication Date Title
ECSP088786A (en) EYE ALLERGY TREATMENTS
CO2017004525A2 (en) Ror-gamma inhibitory dihydropyrrolopyridines
CL2008003096A1 (en) Compounds derived from piperidino-dihydrothienopyrimidines; pde4 inhibitors; pharmaceutical composition comprising them; and use in the treatment of disorders or diseases of the respiratory or gastrointestinal routes, as well as inflammatory diseases of the joints or eyes, among others.
CR10347A (en) ANTIBODIES AGAINST PEPTIDOB-AMILOID
CR9580A (en) AKT ACTIVITY INHIBITORS
CL2007002641A1 (en) COMPOUNDS DERIVED FROM PYRIMIDINS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF ALLERGIC DISORDERS, AUTOIMMUNES, INFLAMMATORY DISEASES.
HN2009001112A (en) AKT ACTIVITY INHIBITORS
ECSP088329A (en) NEW DIAZAESPIROALCANOS AND ITS USE FOR THE TREATMENT OF DISEASES MEDIATED BY CCR8
GT200900283A (en) "COMBINATION THERAPY WITH A COMPOUND ACTING AS AN ADP PLAQUETARY RECEPTOR INHIBITOR".
UY30846A1 (en) OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES
SV2009003299A (en) USED DIHYDROPIRIDINE DERIVATIVES AS INHIBITORS OF PROTEIN QUINASE
CL2008003798A1 (en) Compounds derived from substituted aromatic heterobicycles, py3 kinase inhibitors; pharmaceutical composition; Useful in the treatment of cancer, melanomas, glioblastomas, among other diseases.
GT200600260A (en) BENZAMIDA DERIVATIVES AND USES RELATED TO THE SAME
ECSP109889A (en) THERAPEUTIC COMPOSITIONS AND USES OF THE SAME
CL2013002417A1 (en) Compounds derived from fluoropyridinone; pharmaceutical composition comprising them; and its use in the treatment of bacterial infections.
GT200600163A (en) NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION
AR050717A1 (en) PHARMACEUTICAL COMPOSITIONS
UY30220A1 (en) TETRAHYDROPIRIDOTIENOPIRIMIDINA COMPOUNDS AND METHODS FOR USE
UY30986A1 (en) FLUORINATED DEFERIPRONE DERIVATIVES
HN2012000023A (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES
CL2008002430A1 (en) Benzenesulfonamide derived compounds, cathepsin c inhibitors; pharmaceutical composition comprising them; and its use for the treatment of copd.
CR10277A (en) PIRAZOLQUINOLONAS AS POWERFUL PARP INHIBITORS
CL2010001406A1 (en) Ophthalmic pharmaceutical composition comprising povidone iodine, and a steroidal anti-inflammatory compound, a non-steroidal anti-inflammatory compound, an antibacterial, an anti-allergic or an anti-glaucoma compound; and method to preserve the composition.
ECSP21051825A (en) COMPOUNDS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN DEFICIENCY
ECSP056006A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVE AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNOLOGICALLY MEDIATED DISEASES

Legal Events

Date Code Title Description
FC Refusal